NCT06047730 is a clinical trial of operation ways in Laparoscope, sponsored by Yingchun Ma.

Who is sponsoring NCT06047730?

NCT06047730 is sponsored by Yingchun Ma.

What drugs are being tested in NCT06047730?

Interventions in NCT06047730: operation ways.

What condition does NCT06047730 study?

NCT06047730 studies Laparoscope, Malignant Ovarian Tumor, Single-site Surgery.

Is NCT06047730 still recruiting?

NCT06047730 is currently completed. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT06047730

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Effect Evaluation of Laparoscopic Surgery for Ovarian Benign Tumors by Different Approaches

Completed Last updated 21 September 2023

What this trial tests

trial testing operation ways in Laparoscope in 173 participants. Completed in 31 March 2023.

Timeline

1 January 2017

Primary endpoint
1 July 2022

31 March 2023

Quick facts

Lead sponsor	Yingchun Ma
Status	Completed
Study type	OBSERVATIONAL
Enrollment	173
Start date	1 January 2017
Primary completion	1 July 2022
Estimated completion	31 March 2023
Sites	1 location across China

Drugs / interventions tested

operation ways

Conditions studied

Laparoscope — all drugs for Laparoscope →
Malignant Ovarian Tumor — all drugs for Malignant Ovarian Tumor →
Single-site Surgery — all drugs for Single-site Surgery →

Sponsor

Yingchun Ma

Who can join

Adults 10 to 80, female only, with Laparoscope or Malignant Ovarian Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main purpose: To compare the intraoperative and postoperative recovery of laparoscopic surgery for ovarian benign tumors through different approaches; Secondary objective: Will vNOTES increase the risk of cesarean section during pregnancy and affect the quality of sexual life after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06047730 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yingchun Ma
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06047730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing